Effect of Atypical Antipsychotic Medications on the Risk of Obstructive Sleep Apnea in Individuals With Schizophrenia

Background and Objective Weight gain and obesity could be side effects of taking atypical antipsychotic medications. They are major risk factors for obstructive sleep apnea. The purpose of this study was to investigate effects of atypical antipsychotic medications on the risk of obstructive sleep apnea in individuals with schizophrenia and control groups.Methods In this cross-sectional study, 123 patients with schizophrenia and 107 participants were selected from hospital staff and students using purposive sampling. Data were collected using structured clinical interview and Berlin questionnaires.Results Results showed that the risk of obstructive sleep apnea was significantly higher in individuals with schizophrenia. Age, body mass index, and phases of schizophrenia showed meaningful relationships with the duration of taking atypical antipsychotic medications with the risk of obstructive sleep apnea. However, the type of atypical antipsychotic medications did not have a significant relationship with the risk of obstructive sleep apnea.Conclusions Patients with schizophrenia treated with atypical antipsychotic medicationshave a higher risk of obstructive sleep apnea.

[1]  Peter B. Jones,et al.  Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies , 2021, Molecular Psychiatry.

[2]  Dennis Liu,et al.  Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: A pilot study , 2018, Schizophrenia Research: Cognition.

[3]  M. R. Ghadami,et al.  A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea , 2018, Sleep and Breathing.

[4]  A. Mackinnon,et al.  Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health , 2016, Front. Psychiatry.

[5]  B. James,et al.  Risk of obstructive sleep apnoea syndrome among in-patients at a neuropsychiatric hospital in Nigeria: a short report. , 2015, African health sciences.

[6]  C. Tek,et al.  High rates of obstructive sleep apnea symptoms among patients with schizophrenia. , 2015, Psychosomatics.

[7]  A. Wierzbicka,et al.  Obstructive sleep apnea in severe mental disorders. , 2015, Psychiatria polska.

[8]  T. Lambert,et al.  Obstructive sleep apnoea and schizophrenia--a research agenda. , 2013, Sleep medicine reviews.

[9]  S. Paradiso,et al.  The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. , 2011, Sleep medicine.

[10]  Y. Amoateng-Adjepong,et al.  Atypical Antipsychotic Medications Are Independently Associated With Severe Obstructive Sleep Apnea , 2010, Clinical neuropharmacology.

[11]  W. Riley,et al.  Obesity among those with mental disorders: a National Institute of Mental Health meeting report. , 2009, American journal of preventive medicine.

[12]  M. Mohammadi,et al.  A Persian translation of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: psychometric properties. , 2009, Comprehensive psychiatry.

[13]  C. Shapiro,et al.  Validation of the Berlin Questionnaire and American Society of Anesthesiologists Checklist as Screening Tools for Obstructive Sleep Apnea in Surgical Patients , 2008, Anesthesiology.

[14]  A. Malla,et al.  Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories , 2008, Psychological Medicine.

[15]  E. van Cauter,et al.  Obstructive sleep apnea and type 2 diabetes: interacting epidemics. , 2008, Chest.

[16]  F. Dickerson,et al.  Obesity among individuals with serious mental illness , 2006, Acta psychiatrica Scandinavica.

[17]  C. Moser,et al.  DSM-IV-TR and the Paraphilias , 2006 .

[18]  Terry Young,et al.  Association of psychiatric disorders and sleep apnea in a large cohort. , 2005, Sleep.

[19]  D. Monti,et al.  Sleep in schizophrenia patients and the effects of antipsychotic drugs. , 2004, Sleep medicine reviews.

[20]  Godfrey D Pearlson,et al.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.

[21]  J. Newcomer,et al.  Abnormalities in glucose regulation associated with mental illness and treatment. , 2002, Journal of psychosomatic research.

[22]  Victor Hoflstein.  Relationship between smoking and sleep apnea in clinic population. , 2002, Sleep.

[23]  P. Gourzis,et al.  Symptomatology of the initial prodromal phase in schizophrenia. , 2002, Schizophrenia bulletin.

[24]  J. Winkelman.  Schizophrenia, obesity, and obstructive sleep apnea. , 2001, The Journal of clinical psychiatry.

[25]  D. Jeste,et al.  Sleep-disordered breathing and periodic limb movements in sleep in older patients with schizophrenia , 1999, Biological Psychiatry.

[26]  A. Yung,et al.  The Initial Prodrome in Psychosis: Descriptive and Qualitative Aspects , 1996, The Australian and New Zealand journal of psychiatry.

[27]  G. Drummond,et al.  Comparison of sedation with midazolam and ketamine: effects on airway muscle activity. , 1996, British journal of anaesthesia.

[28]  D. Hodo.  Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry , 1996 .